Heart rhythmWearables

Your smartwatch flagged possible AF: what to save and what to do next

CardioTrack editorialAI-assisted evidence summaryPublished 5 September 2026 3 min read
A smartwatch showing a simple coral heart symbol on an adult wrist beside a blank notebook.
AI-generated editorial illustration. Conceptual, not a diagnostic image or a medical diagram.
About this article: AI-assisted, not independently clinically reviewed

Prepared with AI-assisted research using the sources below. Not independently reviewed by a clinician. Guidance and individual circumstances can change; use this article to prepare for a clinical conversation, not to choose treatment.

Sources checked 2026-09-05. Last updated 2026-09-05.

The short version

  • An optical pulse alert alone cannot diagnose atrial fibrillation.
  • Save the original ECG tracing if available, not just an algorithm label.
  • Do not start aspirin or an anticoagulant because of a watch notification.

A notification about possible atrial fibrillation can arrive when you feel perfectly well. It deserves attention, but the next step is not to diagnose yourself from a small screen. First consider how you feel, then preserve the information that will help a clinician work out whether the alert represents a real rhythm problem.

An alert and an ECG are not the same thing

Many watches look for irregularity using an optical pulse sensor. Some can also record a single-lead ECG. The 2023 US AF guideline states that an initial diagnosis requires a healthcare professional to visually review an ECG signal. Optical pulse patterns alone are insufficient. Even an ECG algorithm's label needs interpretation in context; an unreadable recording is not a reassuring normal result.

Evidence: ACC/AHA/ACCP/HRS 2023: atrial fibrillation guideline

What the Apple Heart Study actually showed

The 2019 Apple Heart Study enrolled 419,297 people; 0.52% received an irregular-pulse notification. Among 450 people who later returned an analysable ECG patch, 34% had AF detected. Separately, among 86 participants with another notification while wearing the ECG patch, the notification's positive predictive value was 84%.

Evidence: Perez et al., NEJM 2019: Apple Heart Study

Those percentages answer different questions. Patches started an average of 13 days after the first notification, and AF can come and go. Neither figure means a watch is '84% accurate for everyone'. This was a single-group, Apple-funded study of volunteers who owned compatible devices, with limited patch returns. It did not prove that population watch screening prevents strokes.

Evidence: Perez et al., NEJM 2019: Apple Heart Study

Why an alert is not a prescription

Trials of implanted-device-detected subclinical AF show why treatment needs careful judgement. In ARTESiA, 4,012 mostly older, higher-risk participants had episodes lasting 6 minutes to 24 hours. Apixaban reduced stroke or systemic embolism from 1.24% to 0.78% per patient-year, but major bleeding was higher: 1.71% versus 0.94% per patient-year. Efficacy and bleeding used different analysis populations, so those figures should not be subtracted into a simple personal net benefit.

Evidence: Healey et al., NEJM 2023/2024: ARTESiA trial

NOAH-AFNET 6 studied a different anticoagulant, comparator and composite outcome in people with implanted-device atrial high-rate episodes. It did not find a statistically significant reduction in its main cardiovascular outcome and found more death or major bleeding. Neither trial studied an isolated consumer-watch alert. They support individual assessment, not self-starting aspirin or a blood thinner.

Evidence: Kirchhof et al., NEJM 2023: NOAH-AFNET 6 trial

Save a small evidence bundle

  • Keep the date and time of the notification and note whether you had symptoms or were asleep, resting or exercising.
  • Export the original ECG PDF or tracing if your device provides one. Keep its device name and recording time with it.
  • Write down how long any symptoms lasted and include a current medication list, particularly any existing anticoagulant.
  • Contact your clinician to arrange review and ask whether a clinical ECG or longer monitor is needed. Repeated alerts should not be left unexplained.
  • If no ECG was captured, say so. Do not redraw a waveform or treat an app's text summary as the original recording.

Evidence: ACC/AHA/ACCP/HRS 2023: atrial fibrillation guideline

A useful appointment question is: 'What evidence would confirm this rhythm, and would confirmation change my treatment?' Avoid repeatedly checking the watch to try to force a diagnosis. The goal is a reliable recording and an appropriate review, not collecting the largest possible number of screenshots.

Symptoms override the device

Chest pain, severe breathing difficulty, fainting or possible stroke symptoms need emergency assessment, whether the watch says normal, AF or nothing at all. In Qatar call 999 for a life-threatening emergency; elsewhere use the local emergency number. Do not delay to charge the watch or obtain another recording.

Evidence: Hamad Medical Corporation: emergency symptoms and Qatar 999

This article is educational and is not medical advice, a diagnosis, or a treatment recommendation. CardioTrack is not intended for diagnosis or treatment. Always discuss your own results with a qualified clinician.

Sources and further reading